GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline

We’re a science-led global healthcare company on a mission to help people to do more, feel better, live longer. Twitter code of conduct on our site
Founded
1830
Follow us
Alexa global traffic share
Twitter followers
Team Size
10000+
Employees
PE HUB , Xconomy

COI Pharmaceuticals acquires Calporta by Merck

Xconomy

After Investing, GSK to Buy Out Celiac Drug Developer Sitari Pharma

MedCity News

GlaxoSmithKline steps into the myeloma game at European hematology conference

MedCity News

AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate

Reuters Top News

GlaxoSmithKline to look for early-stage assets: CEO

PE HUB

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion: Reuters

MedCity News

GlaxoSmithKline to buy cancer-focused Tesaro for $5.1 billion

VCCircle

Unilever wins race for GSK's consumer healthcare biz in India

Adweek

GSK Awards Global Panadol Creative Business to Bespoke WPP Team

VCCircle

Consolidation is the way forward for healthcare: GSK Velu at VCCircle summit

Adweek

GSK Sends $1.5 Billion Media Account to Publicis

VCCircle

Nestle, Unilever, Coke bid for GSK's India Horlicks business

SiliconANGLE

GSK invests $300M into 23andme in return for four-year development partnership - SiliconANGLE

Funding
Reuters Top News , MedCity News

GSK's new R&D head bets on genetics with $300 million 23andMe deal

Earnings Health Science
Adweek

All 6 Major Agency Networks Invited to Pitch for GSK's Global Media Account

Advertising
Bloomberg

GSK Tries to Fix Pharma on a Budget

Health Strategy
Xconomy

As Novartis Buys In to Gene Therapy, GSK Bows Out with Orchard Deal

Health Science Stock markets
Reuters Top News , VCCircle

GSK buys out Novartis in $13 billion consumer healthcare shake-up

Xconomy

Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi

Health
Xconomy

GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up

Health Science